45 KRW
−2.95 B KRW
27.01 B KRW
12.97 M
About GENOFOCUS, INC.
Sector
Industry
CEO
Eui-Joong Kim
Website
Headquarters
Daejeon
Founded
2000
ISIN
KR7187420005
FIGI
BBG008H537V9
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. Its products include enzymes for food, animal, bioconversion and edible vaccines. In addition, It also provides technical services such as library generation, high-throughput screening and consulting services. The company was founded by Pan Jae-Gu, Choi Soo-Geun and Jung Heung-Chae on March 29, 2000 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 187420 is 4,245 KRW — it has increased by 0.95% in the past 24 hours. Watch GENOFOCUS, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOFOCUS, INC. stocks are traded under the ticker 187420.
187420 stock has fallen by −1.51% compared to the previous week, the month change is a 4.43% rise, over the last year GENOFOCUS, INC. has showed a 10.84% increase.
187420 reached its all-time high on Jul 7, 2015 with the price of 26,550 KRW, and its all-time low was 2,350 KRW and was reached on Mar 20, 2020. View more price dynamics on 187420 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
187420 stock is 6.71% volatile and has beta coefficient of 0.04. Track GENOFOCUS, INC. stock price on the chart and check out the list of the most volatile stocks — is GENOFOCUS, INC. there?
Today GENOFOCUS, INC. has the market capitalization of 102.68 B, it has increased by 3.63% over the last week.
Yes, you can track GENOFOCUS, INC. financials in yearly and quarterly reports right on TradingView.
187420 net income for the last quarter is −643.46 M KRW, while the quarter before that showed 175.60 M KRW of net income which accounts for −466.44% change. Track more GENOFOCUS, INC. financial stats to get the full picture.
No, 187420 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 66.00 employees. See our rating of the largest employees — is GENOFOCUS, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOFOCUS, INC. EBITDA is 5.30 B KRW, and current EBITDA margin is −17.86%. See more stats in GENOFOCUS, INC. financial statements.
Like other stocks, 187420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOFOCUS, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOFOCUS, INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOFOCUS, INC. stock shows the neutral signal. See more of GENOFOCUS, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.